Wasimuddin Abdullah: Not Every Hilar ‘Mass’ Is a Mass
Wasimuddin Abdullah, Radiologist at Outlier AI, shared a post on LinkedIn:
“A reminder that not every apparent hilar ‘mass’ is actually a mass.
Recently encountered an interesting vascular case in a 30-year-old female.
Ultrasound and color Doppler demonstrated multiple serpiginous vascular channels at the porta hepatis with non-visualization of the normal main portal vein and associated portal varices – findings consistent with cavernous transformation of the portal vein (portal cavernoma).
What makes this case particularly noteworthy is the presumed congenital etiology.
Most cases of portal cavernoma encountered in practice are secondary to chronic portal vein thrombosis, making congenital presentations in adulthood relatively uncommon.
Key imaging clues:
- Multiple periportal collateral vessels replacing the normal portal vein
- Hepatopetal flow within collateral channels on Doppler
- Associated features of portal hypertension/portal varices
- Absence of a discrete solid mass
Radiology Pearl:
When confronted with a vascular-appearing lesion at the porta hepatis, Color Doppler is often the key to avoiding misdiagnosis.
Recognizing cavernous transformation can prevent unnecessary workup for pancreatic or hilar masses and guide appropriate evaluation for portal hypertension.
Cases like these reinforce why pattern recognition combined with Doppler assessment remains one of the most powerful tools in abdominal ultrasound.
Have you encountered congenital portal cavernoma in an adult patient? I’d be interested to hear about your experience.”
Stay updated with Hemostasis Today.
-
Jul 21, 2026, 13:43Dima Shulkin: Assessing AI-Driven Blood Test Screening for Colorectal Cancer
-
Jul 21, 2026, 13:24Benoit Mores: National Initiative Targets Better Cardiovascular Outcomes
-
Jul 21, 2026, 13:10Paolo Zamboni: Chronic Cerebrospinal Venous Insufficiency Hypothesis in Multiple Sclerosis
-
Jul 21, 2026, 13:05Danai Poutakidou։ The Diagnostic Pitfalls of Unexpected PT/INR Prolongation
-
Jul 21, 2026, 13:00Kefah Mokbel: Beyond Thromboprophylaxis – Enoxaparin’s Emerging Anticancer Signal
-
Jul 21, 2026, 12:56Emmanuel Velazquez-Alvarez: Bridging Innovation and Clinical Practice
-
Jul 21, 2026, 12:53Sandrine Bouteille: A Milestone Presentation at ISTH 2026
-
Jul 21, 2026, 12:40Kalled Musallam: A Comprehensive Review of Thalassemia
-
Jul 21, 2026, 12:34Jim Hoffman: Separating Evidence from Misinformation on Vaccine-Associated Thrombosis